No description
-
2020 (v1)PublicationUploaded on: April 14, 2023
-
2019 (v1)Publication
Background: Stratified medicine methodologies based on subgroup analyses are often insufficiently powered. More powerful personalized medicine approaches are based on continuous scores. Objective: We deployed a patient-specific continuous score predicting treatment response in patients with relapsing-remitting multiple sclerosis (RRMS)....
Uploaded on: April 14, 2023 -
2017 (v1)Publication
Trials of anti-inflammatory therapies in non-relapsing progressive multiple sclerosis (MS) have been stubbornly negative except recently for an anti-CD20 therapy in primary progressive MS and a S1P modulator siponimod in secondary progressive MS. We argue that this might be because trials have been too short and have focused on assessing...
Uploaded on: March 27, 2023 -
2022 (v1)Publication
No description
Uploaded on: February 14, 2024